Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Frontiers in Bioengineering and Biotechnology|March 27, 2025
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapyDariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Biology|April 26, 2025
Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker PotentialMohammad Hosein Nemati, Esmaeil Yazdanpanah, Roya Kazemi, et al.
Vaccines|June 27, 2025
Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved ImmunogenicityMajid Eslami, Bahram Fadaee Dowlat, Shayan Yaghmayee, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2013
Functional redundancy between the XLF and DNA-PKcs DNA repair factors in V(D)J recombination and nonhomologous DNA end joiningValentyn Oksenych, Vipul Kumar, Xiangyu Liu, et al.
Biomedicines|April 29, 2025
HSP<sub>70</sub> Modulators for the Correction of Cognitive, Mnemonic, and Behavioral Disorders After Prenatal HypoxiaOlena Aliyeva, Igor F Belenichev, Ivan Bilai, et al.
Cells|September 27, 2024
The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple SclerosisSepehr Dadfar, Esmaeil Yazdanpanah, Alireza Pazoki, et al.
Nucleic Acids Research|May 24, 2022
DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs)Aleksandr Ianevski, Ronja M Simonsen, Vegard Myhre, et al.
Scandinavian Journal of Immunology|July 13, 2020
Genetic interaction between the non-homologous end-joining factors during B and T lymphocyte development: In vivo mouse modelsSergio Castañeda-Zegarra, Marion Fernandez-Berrocal, Max Tkachov, et al.
Biomedicines|April 29, 2025
A Novel Frontier in Gut-Brain Axis Research: The Transplantation of Fecal Microbiota in Neurodegenerative DisordersMajid Eslami, Zarifeh Adampour, Bahram Fadaee Dowlat, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Possibility of Using NO Modulators for Pharmacocorrection of Endothelial Dysfunction After Prenatal HypoxiaIgor Belenichev, Olena Popazova, Oleh Yadlovskyi, et al.
Pageof 14